Major Breakthrough in Cancer Treatment
In a recent medical trial in the USA, 12 patients were completely cured of rectal cancer without requiring any surgery or chemotherapy.
The trial used a monoclonal antibody - dostarlimab - every three weeks for six months for the treatment of a particular kind of stage two or three rectal cancer.
About Monoclonal Antibodies
- A Monoclonal Antibody is a type of protein (immunoglobulin) that is made in the laboratory from a single B-cell clone and can bind to certain targets in the body, such as antigens on the surface of cancer cells.
- There are many kinds of monoclonal antibodies, and each monoclonal ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 IISc Develops Light-Charged Supercapacitor Technology
- 2 New Nanomaterial Tackles Heavy Metal Contamination
- 3 INCOIS Unveils ‘Integrated Ocean Energy Atlas’
- 4 IISc Develops Brain-Like AI Computing Platform
- 5 India Launches Three Indigenous Supercomputers
- 6 Indigenous Light Tank 'Zorawar'
- 7 ABHED: India’s Cutting-Edge Bulletproof Jacket
- 8 India’s Venus Orbiter Mission
- 9 Thermal Imaging Operations by ISRO’s EOS-08 Satellite
- 10 2024 PT5: A Temporary “Mini-Moon” of Earth
